The information WuXi Bio disclosed on Investor Day was disappointing, leading to share price plunge.2023's growth is worrying. It's too early to expect a rebound in 2024. Share price is under pressure
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.